217 related articles for article (PubMed ID: 18563180)
1. CTLA-4 is a direct target of Wnt/beta-catenin signaling and is expressed in human melanoma tumors.
Shah KV; Chien AJ; Yee C; Moon RT
J Invest Dermatol; 2008 Dec; 128(12):2870-9. PubMed ID: 18563180
[TBL] [Abstract][Full Text] [Related]
2. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
[TBL] [Abstract][Full Text] [Related]
3. Wnt/β-catenin signaling is stimulated by α-melanocyte-stimulating hormone in melanoma and melanocyte cells: implication in cell differentiation.
Bellei B; Pitisci A; Catricalà C; Larue L; Picardo M
Pigment Cell Melanoma Res; 2011 Apr; 24(2):309-25. PubMed ID: 21040502
[TBL] [Abstract][Full Text] [Related]
4. Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model.
Chien AJ; Moore EC; Lonsdorf AS; Kulikauskas RM; Rothberg BG; Berger AJ; Major MB; Hwang ST; Rimm DL; Moon RT
Proc Natl Acad Sci U S A; 2009 Jan; 106(4):1193-8. PubMed ID: 19144919
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of the Wnt/beta-catenin signaling pathway in canine cutaneous melanotic tumor.
Han JI; Kim DY; Na KJ
Vet Pathol; 2010 Mar; 47(2):285-91. PubMed ID: 20139375
[TBL] [Abstract][Full Text] [Related]
6. The WNT/Beta-catenin pathway in melanoma.
Larue L; Delmas V
Front Biosci; 2006 Jan; 11():733-42. PubMed ID: 16146765
[TBL] [Abstract][Full Text] [Related]
7. Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy.
Holtzhausen A; Zhao F; Evans KS; Tsutsui M; Orabona C; Tyler DS; Hanks BA
Cancer Immunol Res; 2015 Sep; 3(9):1082-95. PubMed ID: 26041736
[TBL] [Abstract][Full Text] [Related]
8. The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression.
Schepsky A; Bruser K; Gunnarsson GJ; Goodall J; Hallsson JH; Goding CR; Steingrimsson E; Hecht A
Mol Cell Biol; 2006 Dec; 26(23):8914-27. PubMed ID: 17000761
[TBL] [Abstract][Full Text] [Related]
9. WLS inhibits melanoma cell proliferation through the β-catenin signalling pathway and induces spontaneous metastasis.
Yang PT; Anastas JN; Toroni RA; Shinohara MM; Goodson JM; Bosserhoff AK; Chien AJ; Moon RT
EMBO Mol Med; 2012 Dec; 4(12):1294-307. PubMed ID: 23129487
[TBL] [Abstract][Full Text] [Related]
10. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells.
Lee HS; Park MH; Yang SJ; Park KC; Kim NS; Kim YS; Kim DI; Yoo HS; Choi EJ; Yeom YI
Life Sci; 2007 Jan; 80(7):690-8. PubMed ID: 17157329
[TBL] [Abstract][Full Text] [Related]
11. The WNT-less wonder: WNT-independent β-catenin signaling.
Aktary Z; Bertrand JU; Larue L
Pigment Cell Melanoma Res; 2016 Sep; 29(5):524-40. PubMed ID: 27311806
[TBL] [Abstract][Full Text] [Related]
12. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
Dehner M; Hadjihannas M; Weiske J; Huber O; Behrens J
J Biol Chem; 2008 Jul; 283(28):19201-10. PubMed ID: 18487207
[TBL] [Abstract][Full Text] [Related]
13. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
14. The role of Wnt/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines.
Kovacs D; Migliano E; Muscardin L; Silipo V; Catricalà C; Picardo M; Bellei B
Oncotarget; 2016 Jul; 7(28):43295-43314. PubMed ID: 27175588
[TBL] [Abstract][Full Text] [Related]
15. Wnt/β-catenin signaling inhibitor ICG-001 enhances pigmentation of cultured melanoma cells.
Kim KI; Jeong DS; Jung EC; Lee JH; Kim CD; Yoon TJ
J Dermatol Sci; 2016 Nov; 84(2):160-168. PubMed ID: 27567978
[TBL] [Abstract][Full Text] [Related]
16. Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth.
Fillmore RA; Mitra A; Xi Y; Ju J; Scammell J; Shevde LA; Samant RS
Int J Cancer; 2009 Aug; 125(3):556-64. PubMed ID: 19358268
[TBL] [Abstract][Full Text] [Related]
17. Identification of aryl hydrocarbon receptor as a putative Wnt/beta-catenin pathway target gene in prostate cancer cells.
Chesire DR; Dunn TA; Ewing CM; Luo J; Isaacs WB
Cancer Res; 2004 Apr; 64(7):2523-33. PubMed ID: 15059908
[TBL] [Abstract][Full Text] [Related]
18. Identification of transcriptional targets of Wnt/beta-catenin signaling in dermal papilla cells of human scalp hair follicles: EP2 is a novel transcriptional target of Wnt3a.
Shin H; Kwack MH; Shin SH; Oh JW; Kang BM; Kim AA; Kim J; Kim MK; Kim JC; Sung YK
J Dermatol Sci; 2010 May; 58(2):91-6. PubMed ID: 20347274
[TBL] [Abstract][Full Text] [Related]
19. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
[TBL] [Abstract][Full Text] [Related]
20. Tumor evasion may occur via expression of regulatory molecules: a case for CTLA-4 in melanoma.
Weber JS
J Invest Dermatol; 2008 Dec; 128(12):2750-2. PubMed ID: 18997841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
